Showing results (1701-1710 of 1,881) with videos related to

Sort By:
Pageof 189
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2017
Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancerDebashree Basudhar, Sharon A Glynn, Madison Greer, et al.
Nano Letters|December 7, 2017
Lattice-Matched Epitaxial Graphene Grown on Boron NitrideAndrew Davies, Juan D Albar, Alex Summerfield, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|January 3, 2026
[Clinical and genetic features of Chinese patients with Birt-Hogg-Dubé syndrome]X M Chen, X Y Xie, X H Zhang, et al.
Oncogene|April 4, 2017
Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasisC-J Ko, S-W Lan, Y-C Lu, et al.
Vaccine|June 14, 2022
Strength and durability of antibody responses to BNT162b2 and CoronaVacBenjamin J Cowling, Irene O L Wong, Eunice Y C Shiu, et al.
Journal of Neurosurgery|February 10, 2018
Factors associated with burnout among US neurosurgery residents: a nationwide surveyFrank J Attenello, Ian A Buchanan, Timothy Wen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 23, 2019
MicroRNA-135a-3p regulates angiogenesis and tissue repair by targeting p38 signaling in endothelial cellsBasak Icli, Winona Wu, Denizhan Ozdemir, et al.
Plos One|September 8, 2012
Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activationLisa A Ridnour, Kimberly M Barasch, Alisha N Windhausen, et al.
Journal of Virology|May 27, 2026
Strain-specific differences in the response to egg-derived versus recombinant protein influenza vaccinesAndrea N Loes, Rosario Araceli L Tarabi, Shuk Hang Li, et al.
The Lancet. Oncology|May 29, 2021
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trialThomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, et al.
Pageof 189